Literature DB >> 6098466

Trans activation of transcription by herpes virus products: requirement for two HSV-1 immediate-early polypeptides for maximum activity.

R D Everett.   

Abstract

The transcriptional programme of the herpes viruses is organised into three principal phases. The immediate-early (IE) genes are the first to be transcribed, by the pre-existing host RNA polymerase II, and their promoters are strongly stimulated by a polypeptide component of the virus particle. The E and L gene promoters become active only after the appearance of IE gene products. Genetic and biochemical evidence has shown that the HSV-1 IE polypeptide Vmw175 (ICP 4) is essential for the trans activation of HSV early promoters, but the role of none of the other four IE gene products was known. This paper describes functional tests that show, by co-transfection of recombinant plasmids into HeLa cells, that (i) Vmw175 alone can activate an HSV-1 E gene promoter, (ii) the four other HSV-1 IE gene products by themselves are unable to activate transcription, (iii) the combination of Vmw175 plus the product of IE gene 1, Vmw110 (ICP 0), is a much better activator than Vmw175 alone, (iv) cloned IE gene products of human cytomegalovirus (CMV), varicella-zoseter virus (VZV) and pseudorabies virus (PRV) can also activate transcription from an HSV-1 early promoter, and (v) this activation also occurs with cellular promoters.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6098466      PMCID: PMC557829          DOI: 10.1002/j.1460-2075.1984.tb02270.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  41 in total

1.  Regulation of herpesvirus macromolecular synthesis. VIII. The transcription program consists of three phases during which both extent of transcription and accumulation of RNA in the cytoplasm are regulated.

Authors:  P C Jones; B Roizman
Journal:  J Virol       Date:  1979-08       Impact factor: 5.103

2.  Regulation of herpesvirus macromolecular synthesis. V. Properties of alpha polypeptides made in HSV-1 and HSV-2 infected cells.

Authors:  L Pereira; M H Wolff; M Fenwick; B Roizman
Journal:  Virology       Date:  1977-04       Impact factor: 3.616

3.  Temporal regulation of herpes simplex virus type 1 transcription: location of transcripts on the viral genome.

Authors:  J B Clements; R J Watson; N M Wilkie
Journal:  Cell       Date:  1977-09       Impact factor: 41.582

4.  Control of protein synthesis in herpesvirus-infected cells: analysis of the polypeptides induced by wild type and sixteen temperature-sensitive mutants of HSV strain 17.

Authors:  H S Marsden; I K Crombie; J H Subak-Sharpe
Journal:  J Gen Virol       Date:  1976-06       Impact factor: 3.891

5.  Control of herpes simplex virus type 1 mRNA synthesis in cells infected with wild-type virus or the temperature-sensitive mutant tsK.

Authors:  C M Preston
Journal:  J Virol       Date:  1979-01       Impact factor: 5.103

6.  Regulation of herpesvirus macromolecular synthesis. I. Cascade regulation of the synthesis of three groups of viral proteins.

Authors:  R W Honess; B Roizman
Journal:  J Virol       Date:  1974-07       Impact factor: 5.103

7.  Regulation of synthesis of herpes simplex type 1 virus mRNA during productive infection.

Authors:  R I Swanstrom; E K Wagner
Journal:  Virology       Date:  1974-08       Impact factor: 3.616

8.  Abnormal properties of an immediate early polypeptide in cells infected with the herpes simplex virus type 1 mutant tsK.

Authors:  C M Preston
Journal:  J Virol       Date:  1979-11       Impact factor: 5.103

9.  Evidence that herpes simplex virus DNA is transcribed by cellular RNA polymerase B.

Authors:  F Costanzo; G Campadelli-Fiume; L Foa-Tomasi; E Cassai
Journal:  J Virol       Date:  1977-03       Impact factor: 5.103

10.  Herpes simplex virus gene expression in transformed cells. I. Regulation of the viral thymidine kinase gene in transformed L cells by products of superinfecting virus.

Authors:  J M Leiden; R Buttyan; P G Spear
Journal:  J Virol       Date:  1976-11       Impact factor: 5.103

View more
  242 in total

1.  Multiple immediate-early gene-deficient herpes simplex virus vectors allowing efficient gene delivery to neurons in culture and widespread gene delivery to the central nervous system in vivo.

Authors:  C E Lilley; F Groutsi; Z Han; J A Palmer; P N Anderson; D S Latchman; R S Coffin
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

2.  Perturbation of cell cycle progression and cellular gene expression as a function of herpes simplex virus ICP0.

Authors:  W E Hobbs; N A DeLuca
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

3.  Herpesvirus mRNAs are sorted for export via Crm1-dependent and -independent pathways.

Authors:  T M Soliman; S J Silverstein
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

4.  Efficient activation of viral genomes by levels of herpes simplex virus ICP0 insufficient to affect cellular gene expression or cell survival.

Authors:  W E Hobbs; D E Brough; I Kovesdi; N A DeLuca
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

5.  Herpes simplex virus type 1 ICP0 protein does not accumulate in the nucleus of primary neurons in culture.

Authors:  X p Chen; J Li; M Mata; J Goss; D Wolfe; J C Glorioso; D J Fink
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

6.  The initiator element in a herpes simplex virus type 1 late-gene promoter enhances activation by ICP4, resulting in abundant late-gene expression.

Authors:  Dool-Bboon Kim; Susan Zabierowski; Neal A DeLuca
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

7.  Truncation of the C-terminal acidic transcriptional activation domain of herpes simplex virus VP16 renders expression of the immediate-early genes almost entirely dependent on ICP0.

Authors:  K L Mossman; J R Smiley
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

8.  The regions important for the activator and repressor functions of herpes simplex virus type 1 alpha protein ICP27 map to the C-terminal half of the molecule.

Authors:  M A Hardwicke; P J Vaughan; R E Sekulovich; R O'Conner; R M Sandri-Goldin
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

Review 9.  HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part I. HSV-1 structure, replication and pathogenesis.

Authors:  A Jacobs; X O Breakefield; C Fraefel
Journal:  Neoplasia       Date:  1999-11       Impact factor: 5.715

10.  Herpes simplex virus type 1 ICP0 plays a critical role in the de novo synthesis of infectious virus following transfection of viral DNA.

Authors:  W Z Cai; P A Schaffer
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.